SpineZone Raises $12 Million Series A Round From Polaris Partners, Providence Ventures and Martin Ventures

Funding Rounds

Summary

SpineZone uses its online platform, data-driven personalized treatment programs, and in-person clinics to treat back and neck pain more effectively, while minimizing the need for prescription drugs, injections, and surgeries. “During my 25-year career as a spine surgeon, I noticed a dramatic increase in patients who were receiving surgery for back and neck pain, but who were not getting their desired long-term result,” Kamshad Raiszadeh, M.D., co-founder and Chief Medical Officer of SpineZone, said. In 2014, founder of RxMatch, Inc., Kian left his surgical practice to further develop a software solution to blend technology with science to create a truly exceptional medical delivery platform. SpineZone has more than 10 years of data based on successful patient outcomes and is now ready to expand beyond spine and neck treatment into other musculoskeletal conditions as a comprehensive platform for orthopedic care. SpineZone has built upon years of data and proven improvements in patient outcomes to develop a better software solution that combines technology and orthopedic science to create a truly exceptional medical delivery system.

$ Funding

$
Amount $12.0M Total raised
Date February 25, 2021 Announcement date
Investors Providence Ventures, Martin Ventures, Polaris Partners Lead investors
Company https://www.spinezone.com Funded company

Classifications

industries
No industries detected
applications
No applications detected

AskAI Classifications

Labels
No AI classifications detected

Linked Companies